Watch Ticker

RAPT Therapeutics, Inc. Common Stock

Go to RAPT Therapeutics, Inc. Common Stock Website

$10.10

0.00 (0.00%)
Live
Previous Close

$10.1

Day Range

$0 - $0

Previous Day Range

$10.09 - $10.76

Market Cap

$177.9 million USD

Day Vol.

0

Previous Day Vol.

38145

Currency

USD

Primary Exchange

Nasdaq

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

RAPT Therapeutics, a clinical-stage biopharmaceutical company, announced the appointment of two new directors to its board. The company's lead product candidate, RPT904, is in late-stage development for treating allergic diseases.

Related tickers: RAPT.

Read Full Article

RAPT Therapeutics, a clinical-stage biopharmaceutical company, announced the appointment of Lori Lyons-Williams as the new chair of its board of directors, succeeding William Rieflin. Lyons-Williams is an industry veteran with over 20 years of experience in the pharmaceutical and biotech sectors.

Related tickers: RAPT, CTNM.

Read Full Article
Trending Tickers

Please sign in to view